Advocate Group LLC Astrazeneca PLC Transaction History

Advocate Group LLC

$602 Million
Q4 2025

A detailed history of Advocate Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Advocate Group LLC holds 12,221 shares of AZN stock, worth $1.09 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

12,221

Previous 12,531 2.47%

Holding current value

$1.09 Million

Previous $961,000 13.63%

% of portfolio

0.18%

Previous 0.16%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 20, 2026	SELL	$81.15 - $89.4 $25,156 - $27,714	-310 Reduced 2.47%	12,221 $1.09 Million
Q3 2025 Oct 20, 2025	SELL	$68.72 - $82.11 $2,267 - $2,709	-33 Reduced 0.26%	12,531 $961,000
Q2 2025 Jul 25, 2025	SELL	$64.87 - $75.0 $7,914 - $9,150	-122 Reduced 0.96%	12,564 $877,000
Q4 2024 Jan 21, 2025	SELL	$63.2 - $79.58 $379 - $477	-6 Reduced 0.05%	12,686 $831,000
Q3 2024 Oct 08, 2024	SELL	$76.67 - $87.62 $1,916 - $2,190	-25 Reduced 0.2%	12,692 $988,000

Q1 2024 Apr 25, 2024	SELL	$61.03 - $69.57 $14,830 - $16,905	-243 Reduced 1.88%	12,717 $861,000
Q4 2023 Jan 19, 2024	SELL	$61.89 - $69.28 $62,199 - $69,626	-1,005 Reduced 7.2%	12,960 $872,000
Q3 2023 Oct 17, 2023	SELL	$64.85 - $71.7 $31,192 - $34,487	-481 Reduced 3.33%	13,965 $945,000
Q2 2023 Jul 20, 2023	SELL	$69.91 - $75.81 $34,046 - $36,919	-487 Reduced 3.26%	14,446 $1.03 Million
Q1 2023 Apr 19, 2023	SELL	$63.15 - $71.6 $70,159 - $79,547	-1,111 Reduced 6.92%	14,933 $1.04 Million
Q4 2022 Jan 18, 2023	SELL	$54.21 - $70.44 $64,997 - $84,457	-1,199 Reduced 6.95%	16,044 $0
Q3 2022 Oct 19, 2022	SELL	$53.02 - $135.75 $13,785 - $35,295	-260 Reduced 1.49%	17,243 $946,000
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $1.04 Million - $1.25 Million	17,503 New	17,503 $1.16 Million

Others Institutions Holding AZN

# of Institutions

1,543

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advocate Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advocate Group LLC with notifications on news.

Account

Advocate Group LLC Astrazeneca PLC Transaction History